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httpVacuum-assisted wound closure versus alginate for
the treatment of deep perivascular wound infections
in the groin after vascular surgery
Christina Monsen, RN, MSc,a Christine Wann-Hansson, RN, PhD,b,c Catharina Wictorsson, RN,a and
Stefan Acosta, MD, PhD,a Malmö and Lund, Sweden
Background: Vacuum-assisted wound closure (VAC) therapy may heal wounds faster than conventional dressings after
surgical debridement of perivascular groin infections after vascular surgery.
Methods: Patients with deep infected wounds (Szilagyi grade III) were surgically revised and left open for secondary
healing, then randomized to either VAC or alginate (Sorbalgon) therapy, between February 2007 and November 2011.
To test the hypothesis, it was calculated that 42 patients needed to be included (90% power, 5% level of signiﬁcance). It
was decided to perform an interim analysis after inclusion of 20 patients.
Results: Among 66 patients undergoing groin revision, 20 patients were included in this study. Patients were randomized
to VAC (n [ 10) or alginate (n [ 10). The two groups were comparable in patient and wound characteristics. Time to
full skin epithelialization was signiﬁcantly shorter in the VAC group (median, 57 days) compared with the alginate group
(median, 104 days; P[ .026). The number of positive wound cultures of bacteria and C-reactive protein values decreased
equally in both groups between surgical revision and day 21. One femur amputation was performed in each group as
a consequence of the groin infection, one patient died during the in-hospital stay in the alginate group, and none died in
the VAC group.
Conclusions: VAC achieves faster healing than alginate therapy after wound debridement for deep perivascular wound
infections in the groin after vascular surgery. This ﬁnding does not allow further inclusion of patients from an ethical
point of view, and this study was, therefore, stopped prematurely. (J Vasc Surg 2014;59:145-51.)Wound infection in the groin is a common problem
after vascular surgery. Deep perivascular wound infection
in the groin after arterial surgery is related to severe
morbidity, long and costly hospital stay, leg amputation,
and death.1 Thus, a deep perivascular wound infection in
the groin means great suffering for the patient. Vacuum-
assisted wound closure (VAC) therapy is a form of negative
pressure wound therapy (NPWT) that has been reported to
have several beneﬁcial effects on healing wounds such as
creation of a moist wound-healing environment, drainage
of superﬂuous ﬂuid, reduction of tissue edema, cleansing
deep wounds from bacteria, acceleration of the formation
of vascularized granulation tissue, and faster approximation
of wound edges.2,3 VAC therapy of deep groin infection
after vascular surgery has been reported to be a good
treatment option in relation to a more aggressive surgical
approach.4-6 However, a higher level of evidence is war-
ranted. In the current reports from The Cochranethe Vascular Center, Malmö-Lund, Skåne University Hospital, Mal-
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Technology Assessment,7 research with better quality was
requested. The aim of this prospective randomized
controlled study was to compare VAC vs the other best
treatment (alginate wound dressing) in patients with deep
perivascular groin infection after vascular surgery.
METHODS
Study population and setting. This study was
approved by the local ethics committee at Lund University
(Dnr 616/2006). The study was planned and initiated
before the formal requirement for the registration of inter-
ventional studies in a Clinical Trial Registry. The Vascular
Center, Malmö-Lund, Skåne University Hospital, is
a tertiary referral center for the southernmost part of
Sweden with a primary catchment population of 800,000
inhabitants. Patients undergoing groin incisions for any
vascular procedure were routinely given three prophylactic
doses of the antibiotic dicloxacillin (Ekvacillin), where the
ﬁrst dose was administered at induction of anesthesia.
Patients with deep perivascular groin infections (Szilagyi
grade III)1 were eligible for this study. Patients were
prospectively enrolled, after written informed consent,
between February 13, 2007 and November 24, 2011.
Patients were monitored with wound cultures, blood
sampling, and wound surface area measurement with Vis-
itrak8 (Smith-Nephew, Hull, UK) at one time point each
week during the ﬁrst 3 weeks and followed by personal
nurses connected to the study until the wound was
completely healed.145
Assessed for eligibility
n = 66
Randomized
n = 20
Excluded n = 46
Did not meet inclusion
criteria n = 19
Refused to participate n = 11
Other reasons n = 16
Allocated to VAC n = 10
Received VAC n = 10
Allocated to alginate n = 10
Received alginate n = 10
Lost to follow-up n = 0
Discontinued VAC n = 0
Lost to follow-up n = 0
Discontinued alginate n = 1:
Wound dressing change every six hours
for ten days n = 1
Analysed n = 10
Excluded from wound healing time 
analysis n = 1:
Skin transplantation n = 1
Analysed n = 10
Excluded from wound healing time 
analysis n = 3:
Death prior to healed wound n = 2
Secondary skin closure n = 1A
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Fig 1. CONSORT (CONsolidated Standards Of Reporting Trials) diagram. Patients with deep perivascular groin
infections after vascular surgery throughout the study period VAC, Vacuum-assisted wound closure.
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146 Monsen et al January 2014Randomization. In this randomized study, VAC
therapy was compared with alginate. During the study
period, two different alginate dressings were available: Sor-
balgon (Hartmann ScandiCare AB, Anderstorp, Sweden)
or Melgisorb (Mölnlycke Health Care AB, Götenburg,
Sweden) wound dressings with a high absorptive capacity.
Randomization was performed by C. M. after surgical
debridement, where each patient withdrew a marked
note, “VAC” or “alginate,” from an envelope.
Dressings. Alginate was at the time considered to be
the “best other treatment” choice. Alginate is a dressing
composed of calcium and alga, with a high absorptive
capacity. When the dressing is soaked with wound ﬂuid
and blood, a gel is formed, aiming to retain the superﬂuous
ﬂuid and bacteria within the wound to prevent soggy
damage of the surrounding skin. All patients with deep groin
infections ﬁrst underwent careful wound revision, removal
of all necrotic subcutaneous or skin tissue with scissors or
ladle, and drainage of all infected wound cavities followed
by irrigation with saline, under either regional or general
anesthesia. Wound cultures adjacent to the graft or native
arteries were obtained. After adequate hemostasis, Aquacel
Hydroﬁber (ConvaTec, Bromma, Sweden) was applied to
ﬁll the wound cavity before an outer wound dressing with
absorptive capacity, Sterilet Ontex (Selefa Trade AB,
Spånga, Sweden), was used to reinforce the inner dressing.
In case of randomization to VAC, VAC therapy was started
the day after the surgical revision, and a polyurethane sponge
was applied with a continuous topical negative pressure of
125 mm Hg. Changes of VAC dressings were performed
three times per week. Visible graft material and native
arteries were covered routinely with a nonadhesive silicon-based dressing (Mepitel, Mölnlycke Health Care AB) to
minimize any possible trauma to the vascular anastomosis or
arterial reconstruction, which hypothetically could be
generated by VAC therapy. In case of randomization to
alginate, dressings were changed as often as clinically indi-
cated. The patients were treated in-hospital as long as any
graft material or native artery was visible. As soon as the
arterial reconstruction was covered with granulation tissue,
in an otherwise ﬁt patient, wound treatment could be
continued at home. The wound was followed up by nurses
connected to the study until full skin epithelialization. Local
complications were documented from the day of wound
debridement and revision to the end of follow-up, April
2, 2012.
Deﬁnitions. Hypertension was deﬁned if the patient
previously had been diagnosed with hypertension or was
taking antihypertensivemedication. Cerebrovascular disease
was considered if there was a history of stroke (cerebral
bleeding or infarction) or transient ischemic attack. Ischemic
heart disease was considered if there was a history of myocar-
dial infarction, angina pectoris, coronary artery bypass graft,
or percutaneous coronary angioplasty. Diabetesmellitus was
noted if the patient had antidiabetic treatment with diet, oral
hypoglycemic agents, or insulin. Smoking included both
current and former tobacco smokers. Anemia was deﬁned
as hemoglobin<134 g/L inmen and<117 g/L in women.
Renal insufﬁciency was deﬁned as creatinine>90mmol/L in
women and >105 mmol/L in men. Failure to wound treat-
ment was deﬁned as a nonhealed wound in the groin after
4 months, visible graft material or femoral artery after
1 month of treatment, or amputation or death as a conse-
quence of the groin infection.
Fig 2. The two modalities of wound dressing treatment are
exempliﬁed in the same patient who had undergone surgical revision
of a deep perivascular wound infection in the left groin after vascular
surgery. Vacuum-assisted wound closure (VAC) therapy applica-
tion: The black sponge is placed within the wound cavity. An
occlusive self-adhesive ﬁlm is then placed above the adjacent skin
and a second black sponge is placed above the skin-protective ﬁlm
and connected with the ﬁrst placed sponge. A semipermeable self-
adhesive ﬁlm covers the two sponges. A cut creating a circular
hole, approximately 3 cm in diameter, in the occlusive ﬁlm is made,
and the suction device is ﬁnally attached and the VAC device acti-
vated at 125 mm Hg of continuous negative pressure. Note the
location of the suction device between the two sponges and the need
of a second sponge bridging to the ﬁrst sponge to safely be able to
place the suction device without risking suction lesions in the skin.
Alginate application: The dressings ﬁll the entire wound cavity, and
the wound is then covered by an outer absorptive dressing.
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analysis were performed using the SPSS for Windows, v.
20.0 (SPSS Inc, Chicago, Ill). Differences in proportions
were analyzed with the c2 test or Fisher exact test. Contin-
uous variables were expressed in median and range, and
group difference analyzed with the Mann-Whitney U test.
Based on a previous study4 where median complete wound
healing time was 55 days in 27 groins, we hypothesized that
wound healing time with alginate wound treatment would
be 30 days longer. To be able to show that VAC treatment is
superior to alginate treatment, with a 90% power and 5%
level of signiﬁcance, we needed to include 42 patients in this
randomized study, 21 in each group.9 Flow of the eligible
patients of the study was expressed with a CONSORT
(CONsolidated Standards Of Reporting Trials) diagram.10
It was decided to perform an interim analysis at the plan-
ning stages of the study after inclusion of 20 patients because
of the previous positive experience and expected superiority
with VAC treatment, and in case of a superior healing
advantage with VAC treatment, the study would be stopped
prematurely for ethical reasons. P values of <.05 were
considered signiﬁcant.
RESULTS
Patients with deep perivascular groin infections
after vascular surgery. There were 66 patients assessed for
eligibility (Fig 1). Nineteen patients did not meet the
inclusion criteria. They are simultaneous VAC therapy of
other wounds (n ¼ 8), inability to comply with the study
protocol during follow-up (n ¼ 6), and inability to
comprehend the study information (n ¼ 5). Eleven
patients refused to participate. The surgeon chose the
method in six patients and four patients chose to be treated
with VAC therapy. In sixteen patients, the surgeons were
unaware of the study. Hence, 46 patients were excluded
and 20 patients were randomized to either VAC therapy
(Fig 2, A) or alginate (Fig 2, B). The 46 excluded patients
were treated with VAC therapy.
Characteristics of the randomized patients. The
indications for vascular or endovascular surgery were
peripheral arterial occlusive disease (VAC group [n ¼ 7];
alginate group [n ¼ 6]), abdominal aortic aneurysm (n ¼
2 for both groups), coronary artery disease (alginate group
[n ¼ 2]), and renal artery disease (VAC group [n ¼ 1]).
The following primary operative procedures were per-
formed: common femoral endarterectomy (VAC group
[n ¼ 1]; alginate group [n ¼ 3]), common femoral endar-
terectomy and stenting of iliac artery (VAC group [n ¼ 3]),
interposition graft in the common femoral artery (n ¼ 1 for
both groups), common femoral artery embolectomy (algi-
nate group [n ¼ 1]), endovascular infrainguinal artery
recanalization (n ¼ 1 for both groups), local intra-arterial
thrombolysis (VAC [n ¼ 1]), endovascular aneurysm
repair (n ¼ 2 for both groups), coronary artery angiog-
raphy (alginate group [n ¼ 2]), and inadvertent femoral
artery catheterization attempting femoral venous access for
hemodialysis (VAC group [n ¼ 1]). Characteristics of the
randomized patient are shown in Tables I and II. Therewas a trend that body mass index was higher (Table I) and
that the wound was deeper after surgical debridement
(Table II) among patients randomized to alginate.
Microbiology. The rate of wound infection with
Staphylococcus aureus or intestinal ﬂora was the same in
the two groups (Table II). Infection with bacteria per-
taining to the intestinal ﬂora was the most common cause
(Table III). Clearances of bacteria from the wounds were
equally slow in both groups (Table III).
According to the wound culture results and testing of
bacterial resistance, 11 patients (seven patients in VAC
and four in alginate group) received antibiotics tested to
be not sensitive to the speciﬁc bacteria cultured for
a time of 1-32 days (4-32 days and 1-17 days, respectively).
The median number of positive wound cultures during
wound treatment was 4.5 (range, 2-6) and 6 (range,
1-13) for the VAC and alginate groups, respectively
(P ¼ .32).
Wound healing. Time to full skin epithelialization was
signiﬁcantly shorter in the VAC (median, 57 days)
compared with the alginate (median, 104 days) group
(P ¼ .026) (Table IV). One patient in the alginate group
had a sustained high frequency of daily dressing changes
and change of patient clothes and bed linens, leading to an
Table I. Characteristics of the randomized patients
VAC (n ¼ 10) Alginate (n ¼10) P value
Sex (M/F) 8/2 5/5 .35
Age, years 71 (60-81) 73 (66-84) .66
Comorbidities
Ischemic heart diseases 5 (50) 8 (80) .35
Diabetes mellitus 4 (40) 7 (70) .37
Cerebrovascular diseases 2 (20) 2 (20) 1.0
Any previous vascular surgery 5 (50) 8 (80) .35
BMIa 26 (22.3-37.3) 31.5 (23.9-39.8) .095
BMI, Body mass index; VAC, vacuum-assisted wound closure.
aWeight (kg)/length2 (m2).
Continuous data are presented as median (range) and categoric data as number (%).
Table II. Surgical- and wound-related factors
VAC (n ¼ 10) Alginate (n ¼ 10) P value
Laboratory test just prior to the surgical revision
C-reactive protein, mg/L 150 (4-473) 128 (9-370) .80
Leukocytes, 109/L 9.3 (6.2-13.5) 11.0 (7.0-14.8) .14
Anesthesia
Regional/general 2/8 4/6 .63
Surgical factors
Multiple previous groin incisions 5 (50) 7 (70) .65
Reoperation for bleeding 5 (50) 4 (40) 1.0
Synthetic graft infection 4 (40) 4 (40) 1.0
Time of index procedure to randomization, days 16 (12-170) 16 (8-110) .44
Wounds and microbiology after surgical revision
Positive culture
Staphylococcus aureus 3 (30) 0 (0) .21
Intestinal ﬂora 9 (90) 7 (70) .58
Wound surface area, cm2 13 (7.6-37.6) 20.5 (4.6-44.5) .58
Wound depth, cm 4 (2.3-8.5) 6 (2.5-13.5) .089
VAC, Vacuum-assisted wound closure.
Continuous data are presented as median (range) and categoric data as number (%).
JOURNAL OF VASCULAR SURGERY
148 Monsen et al January 2014unethical study situation, and it was determined by the
study investigators to cross over to VAC therapy after
10 days of alginate treatment. Wound treatment time was
signiﬁcantly shorter outside hospital in the VAC group
compared with the alginate group (P ¼ .034). There were
no differences in wound surface area after surgical
debridement to 21 days of treatment between the two
groups (Table IV). Reduction of C-reactive protein was the
same in the two groups (Table V).
Amputation and mortality. Five patients underwent
amputation during a median follow-up period of
14 months (range, 2.2-51). Three patients in the VAC
group underwent amputation; one transfemoral amputa-
tion was performed as a consequence of the groin infection,
and two patients underwent transfemoral amputation
because of worsening of the critical limb ischemia. Two
patients in the alginate group underwent amputation; one
transfemoral amputation was performed as a consequence
of the groin infection and one patient underwent minor
amputation (metatarsal) because of worsening of the crit-
ical limb ischemia. One patient died during in-hospital stay
in the alginate group and none died in the VAC group(Table IV). Two and ﬁve patients in the VAC group and
the alginate group, respectively, had died by the end of
follow-up (P ¼ .35).
Analysis of the nonrandomized patients. There was
no difference in the frequency of failed wound treatment
between the nonrandomized (17/46; 37%) and the
randomized (6/20; 30%) patients (P ¼ .59). The median
wound healing time for the nonrandomized patients was
64 days (n ¼ 31; P ¼ .30 vs VAC in the randomized
group).
DISCUSSION
The present prospective randomized controlled study
showed that the wound healing rate was twice as fast
with VAC therapy compared with alginate therapy for peri-
vascular deep groin infections after vascular surgery. Even
though the number of patients available for statistical anal-
ysis was reduced to one-half in relation to the estimated
number needed in the sample size calculation, it was,
nevertheless, possible to show that VAC therapy was supe-
rior to alginate in terms of a faster wound healing. The
median wound healing time in the VAC group was
Table III. Microbiology: Results of the wound cultures
obtained at primary surgical debridement
Bacteria
VAC
(n ¼ 10)
Alginate
(n ¼10)
Intestinal ﬂora
Enterococcus faecalis 4 5
Proteus mirabilis 1 3
Escherichia coli 2
Enterobacter cloacae 2
Klebsiella oxytoca 1
Enterococcus faecium 1
Pseudomonas aeruginosa 1
Serratia marcescens 1
Morganella morganii 1
Bacteroides fragilis 1
Anaerobic bacteriae 1 1
Skin ﬂora
Staphylococcus aureus 3
Staphylococcus epidermidis 1
Staphylococcus species 1
Negative 1 2
Summary of types of bacteria 16 14
Days from
start of study
Number of
patients with
positive cultures
Number of
patients with
positive cultures
0 (surgical debridement) 9 8
7 8 7
14 9 7
21 8 6
VAC, Vacuum-assisted wound closure.
The sum of the number of types of bacteria is more than the number of
wounds; there was growth of more than one type of bacteria in some
wounds.
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study5 and also with the nonrandomized patients that were
eligible for this study. It is difﬁcult to tell if alginate therapy
was the best choice as the best comparative wound treat-
ment option in the control group, but it is hard to see
that any other passive wound treatment would have per-
formed much better. It is likely that the main result of
this study would have remained valid regardless of control
group. In a recent randomized clinical trial including 24
patients, NPWT resulted in two times faster wound healing
than treatment with sodium hypochlorite in patients with
difﬁcult-to-heal wounds.11
The two groups were comparable in terms of age, sex,
and comorbidities. There was a trend that body mass index
was higher, and the wound was deeper after surgical
debridement in the alginate group. Since obese patients
often have multiple skin folds near the groin, wound dress-
ings might be difﬁcult to apply, and disturbances of ﬂuid
leakage to the surrounding skin and secondary skin damage
might be a relatively greater problem among these patients,
leading to a somewhat impaired wound healing.12,13 It
seems advantageous to have a foam dressing applied in
the groin connected to a VAC machine that drains the
exudate continuously away from the wound edges,especially in the obese. On the other hand, a higher
proportion of patients in the alginate group received proper
antibiotic treatment. The level of importance of each of
these factors for healing of deep perivascular wound infec-
tions in the groin is unclear.
The mechanism of action for accelerating wound heal-
ing in VAC therapy has been attributed to various factors.
In contrast to Pinocy et al,14 who found that VAC therapy
rapidly cleared the groin wounds from positive smears with
total elimination of bacteria with 14 days of VAC therapy,
the present study showed a much slower reduction of the
number of positive smears in both groups without differ-
ences between groups. Again, a more appropriate antibiotic
regime after wound debridement might have had an inﬂu-
ence of the reduction of the amount of bacteria at the
different time points in both groups. There is, however,
no scientiﬁc support, so far, that VAC therapy promotes
bacterial clearance from the wound.3 Furthermore, there
was no difference in reduction of C-reactive protein in rela-
tion to time between the two groups.
Although not analyzed in the present study, edema
reduction and control of ﬂuid leakage might be those crit-
ical factors that make VAC superior to alginate therapy in
terms of wound healing. The leakage may sometimes be
signiﬁcant, with an initial drainage of more than 500 mL
of exudates per day. In fact, one patient had to abandon
alginate therapy after 10 days of treatment because of a sus-
tained high frequency of daily dressing changes and change
of patient clothes and bed linens, leading to an unethical
study situation. Another useful clinical implication for the
closed VAC therapy system may be that leakage of infected
ﬂuid is prevented from transmission to other patients.
There are several methods for measuring wound
volume, which would have been the most appropriate
way to follow wound healing. The validity and reproduc-
ibility of all these methods has been questioned, especially
simple and cost-effective methods for routine clinical use.15
Consequently, it was not possible to establish a feasible
bedside method for measuring volume of the wound cavity
in the groin. Therefore, wound surface area together with
wound depth were measured as separate variables during
the ﬁrst 3 weeks, and it was not possible to show that early
wound contraction,16 in terms of wound surface area
reduction, was a mechanism for a faster wound healing in
the VAC group. Instead, wound treatment time after
hospital discharge to complete skin epithelialization was
found to be much shorter in the VAC group. There is
evidence, however, that NPWT achieves faster reduction
of wound volume than conventional dressings in the early
stages of wound healing as well.10
Only 20 patients were included during a long, 4.5-year
study period, which implies that there were difﬁculties in
enrollment of patients. The CONSORT diagram (Fig 1)
indicates that some patients did not meet the inclusion
criteria, whereas 16 patients were not included due to
logistic problems or due to surgeons’ preference of treat-
ment without considering randomization of a potential
study candidate. Both surgeons and patients were probably
Table IV. Wound healing
VAC (n ¼ 10) Alginate (n ¼ 10) P value
Time to full skin epithelialization, days 57 (25-115)
n ¼ 9
104 (57-175)
n ¼ 7
.026
Wound treatment in-hospital stay, days 13 (5-93) 20 (6-76) .79
Wound treatment outside hospital, days 42 (18-81) 79 (32-171) .034
Failure to wound treatmenta 1 (10) 5 (50) .14
Amputation or death following groin infection 1 (10) 1 (10) 1.0
Time (days from start of study) Wound surface area, cm2 Wound surface area, cm2
0 (after surgical debridement) 18.8 (7.6-37.6) 22.3 (4.6-44.5; n ¼ 10) .58
7 12.0 (1.3-44.9) 16.6 (5.9-53.8; n ¼ 10) .48
14 7.5 (0.6-92.5) 10.8 (2.0-33.8; n ¼ 9) .36
21 3.5 (0-92.5) 6.5 (2.7-26.3; n ¼ 9) .24
aFailure to wound treatment ¼ nonhealed wounds in the groin after 4 months, visible graft material or femoral artery after 1 month of treatment, or
amputation or death as a consequence of the groin infection.
Continuous data are presented as median (range) and categoric data as number (%).
Table V. Reduction of C-reactive protein (CRP) during
treatment
Time, days
CRP, mg/L,
median
P valueVAC (n ¼10) Alginate (n ¼ 10)
0 (before surgical
debridement)
149 128 .76
7 11 20 .68
14 7 13 .46
21 6 9 .81
VAC, Vacuum-assisted wound closure.
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therapy at the end compared with the start of study.
However, it is notably difﬁcult to recruit a high proportion
of randomized patients in clinical trials in surgery among
those eligible.17 Since the results after VAC therapy for
perivascular groin infections was perceived as very good,5
accepted by clinicians as the gold standard for treatment,
and preferred by the personnel staff, the ratio of random-
ized patients must be considered as reasonable.
CONCLUSIONS
VAC therapy induced faster wound healing than algi-
nate therapy in patients with deep perivascular wound
infections in the groin after vascular surgery. This ﬁnding
does not allow further inclusion of patients from an ethical
point of view, and this study was, therefore, stopped
prematurely.
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